Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies

Abstract

Recebido em 7/6/10; aceito em 10/1/11; publicado na web em 25/3/11 Nanoparticles were produced by solvent emulsification evaporation method with the following characteristics: nanometric size (238 ± 3 nm), narrow polydispersity index (0.11), negative zeta potential (-15.1 mV), good yield of the process (73 ± 1.5%), excellent encapsulation efficiency (81.3 ± 4.2%) and spherical shape. X-rays diffraction demonstrated the loss of drug crystallinity after encapsulation; however, the profile of the diffractograms of the poly-ε-caprolactone (PCL) nanoparticles was kept. Differential scanning calorimetry thermograms, correspondingly, exhibited the loss of drug melting peak and the increasing of the melting point of the PCL nanoparticles, evidencing an interaction drug-polymer. Naproxen release was low and sustained obeying the Higuchi´s kinetic. The results show that nanoparticles are promising sustained release system to the naproxen.

Surface-functionalized cockle shell–based calcium carbonate aragonite polymorph as a drug nanocarrier

“…Furthermore, these comparable patterns of XRD patterns also demonstrate that the drug molecule was loaded within the nanocarriers. Similar patterns of findings were also observed by other studies 8,21,56,57…”

Novel imatinib-loaded silver nanoparticles for enhanced apoptosis of human breast cancer MCF-7 cells

“…Various nanovectors and nanoconjugate such as polymeric conjugates, synthetic organic nanoparticles like dendrimers (Karimi et al 2014), lipids such as liposomes and micelle (Dicheva andKoning 2014, Gupta et al 2015), carbon nanotubes, inorganic nanoparticles (He et al 2016) are gaining interest as drug delivery platforms (Bhattacharyya et al 2011, Sivasankar andKumar 2010). Nowadays, nanoparticles for controlled local drug delivery are suitable tools to improving serum solubility of the drugs, prolonging the drug release rate, improving the therapeutic index and pharmacokinetics of the drugs in contrast to the free drug counterparts (Mello andRicci-J unior 2011, Singh et al 2011).…”

Action of the anti-tumoral zinc(II)phthalocyanine in solution or encapsulated into nanoparticles of poly- ε -caprolactone internalized by peritoneal macrophages

“…NPs with or without ZnPc were round as already described in [8,9]. The results indicate that the used NPs are stable structures, since the encapsulation induced no significant modification of their average diameter and morphology.…”